Medically Tailored Meals to Reduce Ultra-processed Food Intake in Colorectal Cancer Survivors
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT07701707
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Colorectal Cancer (Diagnosis)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MTM: Medically tailored meals — BEHAVIORAL3 fully prepared, home-delivered, medically tailored meals per day delivered weekly for 6 weeks.
- MTM plus Fresh Produce — BEHAVIORAL2 fully prepared, home-delivered, medically tailored meals per day, plus weekly deliveries of fresh produce and accompanying recipes, for 6 weeks.
- Control group — BEHAVIORALweekly recipes and meal-planning materials only; no food will be provided.
Study Details
This research study is a three-arm, parallel-group randomized clinical trial that examines the feasibility and initial impact of consuming medically tailored meals to reduce intake of ultra-processed food and improve health and survival outcomes among 60 patients with stage I-III colorectal cancer.
Key Dates
- First listed
- Jul 14, 2026
- Start date
- Aug 10, 2026
- Status verified
- Jul 2026
- Primary completion
- Aug 10, 2028
- Completion
- Oct 10, 2028
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Medically Tailored Meals (MTM)3 prepared meals per day (i.e., breakfast, lunch, and dinner) for a total of 126 meals.
- Experimental: Medically Tailored Melas (MTM) plus Fresh Produce2 prepared meals per day (84 meals total), plus weekly fresh produce and recipes to help prepare a third meal each day.
- Active Comparator: Control groupweekly meal planning materials and recipes only; no food will be provided.
Primary Outcome Measure
Evaluation of feasibility of consuming medically tailored meals through study participation [ Time Frame: From enrollment to the end of study, assessed at year 3 follow-up ]
Central Contacts
- Mengxi Du, RD, PhD, MPH617-726-5405
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Mengxi Du, RD, PhD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans AffairsRecruiting · NYU Langone Health · Brooklyn, New York
- ColoSense Post-Approval StudyRecruiting · Geneoscopy, Inc. · St Louis, Missouri
- A Phase I Trial of S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal AdenomasPHASE1 · Not Yet Recruiting · Jun Gong, MD · Los Angeles, California